Watch 2 Min. Video
Unlike with heart disease and cancer, we don't diagnose and treat Alzheimer's Disease until symptoms hit and then we terat the cause, amyloid plaques. We need to stop the amyloid plaques 10-20 years before the person shows symptoms
Rudolf E. Tanzi PH.D.
Kennedy Professor of Neurology, Harvard Medical School &
Vice-Chair, Mass General Hospital Neurology Dept.
THE LUMA TC STORY
The human brain is comprised of 100 billion nerve cells with 500 trillion connections. As you age, your brain wears individually based on environmental stressors, toxic exposure, trauma, disease, hereditary vulnerability, and other influences. Consequently, your nerve cells begin to gradually lose normal function. These nerve cells can become inflamed and begin to build up unhealthy protein deposits called plaques and tangles due to aging and faulty cell processes. At some point, these cells can no longer function normally and die, leaving holes and broken circuitry in the brain.
Our positive findings that daily use of TC (Theracurmin) [found in LumaTC] improves memory and decreases amyloid and tau binding in the amygdala and hypothalamus are encouraging that this relatively inexpensive and nontoxic treatment may have potential for not only improving age-related memory decline but also preventing or arresting progression of neurodegeneration and eventually future symptoms of Alzheimer’s disease.
Gary Small , MD
Educational Presentation
Consider LUMA TC For:
The Alzheimer's Disease Process
Memory Loss
Cognitive Dysfunction
Neuro Imaging (FDDNP PET) Data
The FDDNP-PET findings raise the possibility that decreases in plaque and tangle accumulation in brain regions modulating mood and memory are associated with curcumin supplementation
Clinical Data
LUMA Is An FDA Regulated “Medical Food” Meeting The FDA Strict (IEM) Requirements
Call To Speak To A Representative: (985) 900-1328